(Q35993130)

11 August 2017

1 reference

title

Immunotherapy with monoclonal antibodies in metastatic melanoma (English)

1 reference

11 August 2017

1 reference

1 reference

T. A. Steffens

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1561808

9 October 2022

D. F. Bajorin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1561808

9 October 2022

A. N. Houghton

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1561808

9 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1561808

9 October 2022

publication date

1 March 1992

1 reference

11 August 2017

published in

World Journal of Surgery

1 reference

11 August 2017

volume

16

1 reference

11 August 2017

issue

2

1 reference

11 August 2017

page(s)

261-269

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02071530

11 August 2017

exact match

0 references

cites work

Use of I-131 labeled, murine Fab against a high molecular weight antigen of human melanoma: preliminary experience

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02071530

Stimulation of macrophage tumoricidal activity by the growth and differentiation factor CSF-1.

21 January 2018

1 reference

12 December 2020

Phase I evaluation of a combination of monoclonal antibody R24 and interleukin 2 in patients with metastatic melanoma

1 reference

12 December 2020

Pilot trial of murine monoclonal antibodies in patients with advanced melanoma

1 reference

12 December 2020

Role of activated macrophages in antibody-dependent lysis of tumor cells

1 reference

12 December 2020

Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.

1 reference

12 December 2020

Diagnostic imaging of malignant melanoma with radiolabeled antitumor antibodies

1 reference

12 December 2020

Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2.

1 reference

12 December 2020

Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma

1 reference

12 December 2020

A phase II trial of high-dose cisplatin and dacarbazine. Lack of efficacy of high-dose, cisplatin-based therapy for metastatic melanoma

1 reference

12 December 2020

Modulation of human alveolar macrophage tumoricidal activity by recombinant macrophage colony-stimulating factor

1 reference

12 December 2020

Building a better monoclonal antibody

1 reference

12 December 2020

Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro

1 reference

12 December 2020

Disialoganglioside GD3 on human melanoma serves as a relevant target antigen for monoclonal antibody-mediated tumor cytolysis

1 reference

12 December 2020

Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays

1 reference

12 December 2020

Tissue distribution of GD3 ganglioside detected by mouse monoclonal antibody R24

1 reference

12 December 2020

Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy

1 reference

12 December 2020

Secretory products of macrophages

1 reference

12 December 2020

Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture

1 reference

12 December 2020

Interleukin-2 enhancement of monoclonal antibody-mediated cellular cytotoxicity against human melanoma

1 reference

12 December 2020

Light chain variants of an IgG3 anti-GD3 monoclonal antibody and the relationship among avidity, effector functions, tumor targeting, and antitumor activity

1 reference

12 December 2020

DTIC (NSC-45388) in malignant melanoma: a perspective

1 reference

12 December 2020

Differential in vitro effects of recombinant alpha-interferon and recombinant gamma-interferon alone or in combination on the expression of melanoma-associated surface antigens

1 reference

12 December 2020

Bone marrow progenitors cultured in the presence of granulocyte-macrophage colony-stimulating factor versus macrophage colony-stimulating factor differentiate into macrophages with distinct tumoricidal capacities.

1 reference

12 December 2020

Radioimmunoimaging in malignant melanoma patients with the use of indium-111-labeled antimelanoma monoclonal antibody (ZME-018) to high-molecular-weight antigen.

1 reference

12 December 2020

A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanoma

1 reference

12 December 2020

Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies

1 reference

12 December 2020

Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites

1 reference

12 December 2020

Human monoclonal antibodies to glycolipids and other carbohydrate antigens: dissection of the humoral immune response in cancer patients

1 reference

12 December 2020

Transfectomas provide novel chimeric antibodies

1 reference

12 December 2020

High-dose cisplatin and dacarbazine in the treatment of metastatic melanoma

1 reference

12 December 2020

1 reference

12 December 2020

Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues

1 reference

12 December 2020

Differentiation antigens of melanoma and melanocytes

1 reference

12 December 2020

Monoclonal antibody-defined correlations in melanoma between levels of GD2 and GD3 antigens and antibody-mediated cytotoxicity

1 reference

12 December 2020

Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma

1 reference

12 December 2020

Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor

1 reference

12 December 2020

Immunotoxins to a human melanoma-associated antigen: comparison of gelonin with ricin and other A chain conjugates

1 reference

12 December 2020

Intratumor localization of monoclonal antibody in patients with melanoma treated with antibody to a 250,000-dalton melanoma-associated antigen

1 reference

12 December 2020

Inflammatory tumor response to monoclonal antibody infusion

1 reference

12 December 2020

Monoclonal antibody therapy in malignant melanoma: factors effecting in vivo localization

1 reference

12 December 2020

Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient?

1 reference

12 December 2020

Specificity analysis of human monoclonal antibodies reactive with cell surface and intracellular antigens

1 reference

12 December 2020

Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2

1 reference

12 December 2020

Increased delivery of tumor-specific monoclonal antibodies to brain after osmotic blood-brain barrier modification in patients with melanoma metastatic to the central nervous system.

1 reference

12 December 2020

Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies

1 reference

12 December 2020

Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targets.

1 reference

12 December 2020

Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin

1 reference

12 December 2020

Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments

1 reference

12 December 2020

Effect of antibody dose on the imaging and biodistribution of indium-111 9.2.27 anti-melanoma monoclonal antibody

1 reference

12 December 2020

DTIC therapy in metastatic malignant melanoma: a simplified dose schedule

1 reference

12 December 2020

Phase Ia-Ib trial of an anti-GD3 monoclonal antibody in combination with interferon-alpha in patients with malignant melanoma

1 reference

12 December 2020

Monoclonal antibodies to two determinants of melanoma-antigen p97 act synergistically in complement-dependent cytotoxicity

1 reference

12 December 2020

Scintigraphy with In-111-labeled monoclonal antitumor antibodies: kinetics, biodistribution, and tumor detection

1 reference

12 December 2020

Local distribution and concentration of intravenously injected 131I-9.2.27 monoclonal antibody in human malignant melanoma

1 reference

12 December 2020

Human monoclonal antibody to tumor-associated ganglioside GD2

1 reference

12 December 2020

Scintigraphic detection of metastatic melanoma using indium 111/DTPA conjugated anti-gp240 antibody (ZME-018)

1 reference

12 December 2020

GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma

1 reference

12 December 2020

Continuous cultures of fused cells secreting antibody of predefined specificity

1 reference

12 December 2020

Radiolabeled monoclonal anti-tumor antibodies in diagnosis and therapy

1 reference

12 December 2020

Ganglioside GM2 as a human tumor antigen (OFA-I-1)

1 reference

12 December 2020

Inhibition of growth of human tumor xenografts in athymic mice treated with ricin toxin A chain-monoclonal antibody 791T/36 conjugates

1 reference

12 December 2020

A cell-surface antigen which is present in the ganglioside fraction and shared by human melanomas

1 reference

12 December 2020

Melanoma antigens: immunological and biological characterization and clinical significance

1 reference

12 December 2020

Antibody-mediated killing of human tumor cells by attached effector cells

1 reference

12 December 2020

Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma

1 reference

12 December 2020

Human monoclonal antibody to tumor-associated ganglioside GD2: suppressed growth of human melanoma in nude mice

1 reference

12 December 2020

High-dose, unlabeled, nonspecific antibody pretreatment: influence on specific antibody localization to human melanoma xenografts

1 reference

12 December 2020

Some recent work on tumor immunity

1 reference

12 December 2020

Monoclonal antibody imaging of human melanoma. Radioimmunodetection by subcutaneous or systemic injection

1 reference

12 December 2020

Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma

1 reference

12 December 2020

Reshaping human antibodies for therapy

1 reference

12 December 2020

Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02071530

1 reference

11 August 2017

1 reference